Intelligence · Clinical Development
Pipeline search results
Programs matching “tranexamic acid” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 16 pipeline programs matching "tranexamic acid" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Tranexamic Acid
United Therapeutics Europe Ltd
Spinal Injuries
1 trial -
Tranexamic Acid
Arrowhead Pharmaceuticals Ireland Limited
Hemorrhagic Shock
1 trial -
Tranexamic acid
The First People's Hospital of Lianyungang
Hemorrhage, Postpartum
1 trial -
pad-gauze with tranexamic acid (Hemostopan™)
Sionna Therapeutics
Bleeding
1 trial -
Tranexamic Acid
Neuroscience Trials Australia
Intracerebral Haemorrhage
1 trial -
Tranexamic Acid
United Therapeutics Europe Ltd
Hemorrhage
1 trial -
Tranexamic Acid
United Therapeutics Europe Ltd
Anterior Cruciate Ligament Reconstruction
1 trial -
Tranexamic Acid；
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Iatrogenic Endobronchial Bleeding
1 trial -
SALINE, TRANEXAMIC ACID
Disc Medicine
Slipped capital femoral epiphysis (SCFE), Legg-Calvé-Perthes Disease (LCPD), Neuromuscular conditions, Secondary hip dysplasia, Developmental dysplasia of the hip (DDH)
1 trial -
TRANEXAMIC ACID
The George Institute
Hip fracture
1 trial -
Tranexamic Acid
The First People's Hospital of Lianyungang
Postpartum Hemorrhage， Cesarean Section
1 trial -
Tranexamic Acid 1000 mg/10ml normal saline infusion
United Therapeutics Europe Ltd
Postpartum Hemorrhage
1 trial -
intravenous tranexamic acid (TXA) infusion
The First People's Hospital of Lianyungang
Spontaneous Intracranial Hemorrhage
1 trial -
Tranexamic Acid 100Mg/Ml Inj Vil 10Ml
Hospital Authority, Hong Kong
Rotator Cuff Tears
1 trial -
Tranexamic acid (TXA)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Blood Loss
1 trial -
tranexamic acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Transplantation
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.